I agree Gisano from the trader perspective. I think some here like me, who are also traders but are looking at this a bit differently are not stressing out. Seeing the confirmation that Sanderson was trained and doors are open, just like the company said and we all estimated it would be this week, see the company progressing as reported.
We will see CA, TX, TN and OH next. My gut says more in EMEA as well due to Antonini. We are seeing the testimonials and when ready we will see the trial results.
Investors know that CELZ has done what they said the were going to do, albeit at a slower pace than we like.
The PPS has been beaten half to death which makes the market cap embarrassing, no doubts.
The trader in me hates the PPS. But the investor in me sees a small start up biotech keeping to their word and getting their footprint in this market slowly established. It will pick up speed as we move forward.
I agree with NSX and have said so many times, that these doctors are excited with what the possibilities are with CaverStem and it will start snowballing. Same for the patients.
The problem is see is this is still vastly unknown. For example, look at the Facebook post from CaverStem announcing Sanderson. 9 likes as I type this. No one is seeing it. Agree they need to PR this stuff.
My belief is that when the foundation is firmer (pun intended) the gloves will come off and they will start issuing press releases for this kind of event.
As this continues to pick up speed with both doctors and patients it will snowball fast and the market will adjust and will the PPS and market cap.
This won’t be unknown for long is my prediction.
I am not saying this happens this week or the following week. It will happen all summer and be capped off by verification when Q2 comes out in August.
Like them or not, the scientific brains behind this is not arguable. And whether is turns out to be right or wrong in the long run, the board as some nice prior successes to hang their hats on. Let them spin this up when ready.
